Results 31 to 40 of about 5,191 (294)
Pharmaceuticals, 2022 Ulcerative colitis (UC) is an inflammatory bowel disease that affects the patients’ colorectal area culminating in an inflamed ‘leaky gut.’ The majority of UC treatments only provide temporary respite leading to its relapse.
Acharya Balkrishna +6 more
doaj +1 more source
Formulation and Evaluation of Delayed Release Enteric Coated Tablets of Tenatoprazole, by Optimizing the Plymers [PDF]
Trends in Pharmaceutical Sciences, 2020 The present study was undertaken with an aim to formulate enteric coated tablets of Tenatoprazole (a novel proton pump inhibitor with an imidazopyridine ring) to improve bioavailability by avoiding degradation.
Nikunja B Pati +3 more
doaj +1 more source
Effects of thickened drinks on the disintegration of various oral tablets
Heliyon, 2020 Food thickeners are widely used to aid the oral administration of medications to patients with dysphagia. Powder-type food thickeners are used to modulate the viscosity of therapeutic solutions depending on the swallowing capacity of patients.
Taisuke Matsuo +3 more
doaj +1 more source
Preformulation and preliminary formulation studies of mesalazine gastro-resistant tablets [PDF]
Romanian Journal of Pharmaceutical Practice, 2020 Mesalamine, 5-aminosalicylic acid or mesalazine is the standard therapy of inflammatory bowel disease. A small number of pharmaceutical dosage forms with mesalazine are on the market.
Adriana Aurelia Chiş +5 more
doaj +1 more source
Formulation and evaluation of enteric coated tablets of proton pump inhibitor. [PDF]
J Basic Clin Pharm, 2010 Nair AB +4 more
europepmc +2 more sources
Development of a multiparticulate system containing enteric-release mini-tablets of omeprazole
Brazilian Journal of Pharmaceutical Sciences, 2014 The main aim of this study was to develop a multiparticulate system containing mini-tablets of omeprazole formulated with an enteric polymer with pH-dependent solubility.
Volnei Jose Tondo Filho +3 more
doaj +1 more source
Saudi Pharmaceutical Journal, 2019 Diclofenac sodium (DS) a non-steroidal anti-inflammatory drug has a bitter taste and is a local stomach irritant. The aim of this study was to formulate taste masked DS orally dispersible tablets (ODTs) with targeted drug release in the intestine ...
Hadyah Faleh Alotaibi +4 more
doaj +1 more source
Fractional iron absorption from enteric-coated ferrous sulphate tablet
Indian Journal of Medical Research, 2020 Background & objectives: Iron supplementation is widely used public health measure to manage iron deficiency anaemia. In India, enteric-coated iron tablets are administered to adolescent boys and girls to avoid adverse effects such as gastritis, which reduces compliance, but this may result in poor iron absorption.
Thankachan, Prashanth +4 more
openaire +2 more sources
Frontiers in Psychiatry, 2022 Neuropsychiatric systemic lupus erythematosus is a serious complication of systemic lupus erythematosus. A 33-year-old female patient had repeated hair loss for more than 3 years.
Xun He, Xi-Ling Duan, Jing-Song Liu
doaj +1 more source
Drug Design, Development and Therapy, 2023 Duanduan Cong,1 Wenyuan Qi,1 Xiaohui Liu,1 Xiaoyu Xu,1 Lingyun Dong,2 Wei Xue,1,* Kexin Li1,* 1Clinical Trial Center, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing ...
Cong D +6 more
doaj